OMX30 1 662 1,0%  OMXH25 4 354 0,9%  Bitcoin 6 733,11 0,2%  Dow 26 744 0,3%  Nas 7 531 -0,5%  EUR 10,3309 -0,1%  USD 8,7923 0,0%  Olja 78,8 0,1%  Guld 1 200 -0,6% 

Ipsen Aktie

143,20EUR -1,35EUR -0,93%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Fundamentala nyckeltal för Ipsen

2017 2018e 2019e 2020e 2021e
Utdelning 0,87 1,08 1,19 1,36 1,45
Direktavkastning (i %) 0,86 0,75 0,83 0,94 1,01
PE-tal 23,27 24,94 20,47 17,09 14,97
Resultat/aktie 4,36 5,76 7,01 8,40 9,59

Nyheter om Ipsen

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Ipsen

ytterligare analyser

Ipsen Peer Group

Ipsen 143,20
-0,9%
pagehit

Lägg till instrument

Vad tycker du?

Profil Ipsentill bolagsprofilen

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults and children; and Fortrans, a colon cleansing solution indicated for patients in preparation for endoscopic, radiological examinations or colonic surgery. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Realtidskurs Ipsen

Bid 141,45 EUR Ask 144,00 EUR
Kurstid 15:39 Börsen STU

Aktiekurs Ipsen i EURPUSH CHART

Kurs 143,20 EUR -1,35 -0,93 %
Kurstid 17:35:12
Datum 21.09.2018
Öppning 144,60
Gårdagen 144,55
Dagshögsta 145,75
Dagslägsta 141,90
52 v. högsta 155,95
52 v. lägsta 97,24
52 v. perf.
Volym (Antal) 196 543
Börsvärde (SEK) 124,27 Mrd
Börsen
Kurs för 143,20 EUR från börsen Paris motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 1 479,38 SEK.

Till aktien Ipsen

Ticker
ISIN FR0010259150
Index CAC MID 60, SBF 120

Ipsen Nyckeltal

Börsvärde i SEK 124,27 Mrd
Free float %
Antal aktier mio. 83,79
Cashflow/aktie i lokal valuta 4,93
Bokvärde/aktie i lokal valuta 18,38
60 dagar vola 18,58
PBV

Ipsen Historiska kurser

2018-09-21 143,20 196 543
2018-09-20 144,55 84 442
2018-09-19 145,00 107 930
2018-09-18 145,95 138 136
2018-09-17 145,45 132 146